Our Comments on FDA’s Draft Guidance for Predetermined Change Control for AI/ML Devices

M. Jason Brooke
July 3, 2023

M. Jason Brooke shares his practical and legal concerns with the new draft guidance affecting AI/ML-enabled device software functions, requesting that the Agency ensures clarity and consistency with U.S. regulations and effective FDA policy.

Keep in Touch

Fill out this form to get started.

Stay in the loop with exclusive insights and valuable updates about the medical device industry and FDA approval!

Thank you! Keep an eye on your inbox for updates.
Oops! Something went wrong while submitting the form.